Resources
About Us
Home Report
Store
Specialty Enzymes Market
Specialty Enzymes Market Size, Share, Forecast, & Trends Analysis by Source (Microorganism, Plant, Animal) Type (Carbohydrases, Protease, Lipase), Form (Liquid), Application (Pharmaceutical, Diagnostics, Research & Biotechnology) — Global Forecast to 2031
Report ID:MRFB - 1041377 Pages: 170 Oct-2024 Formats*: PDF Category: Food and Beverages Delivery: 24 to 72 HoursThe Specialty Enzymes Market was valued at $3.58 billion in 2023. This market is projected to reach $6.47 billion by 2031 from an estimated $3.84 billion in 2024, at a CAGR of 7.7% during the forecast period from 2024 to 2031.
Specialty Enzymes Market Size & Forecast
Key factors driving the growth of this market include the growing prevalence of chronic disorders, increasing demand from pharmaceuticals and biotechnology, and advancements in production technologies. Moreover, increasing focus on sustainable and eco-friendly processes and the expanding application of biocatalysts are expected to create market growth opportunities for the stakeholders in this market.
Key Findings Specialty Enzymes Market
- By Source: The Microorganism Segment to Dominate the Specialty Enzymes Market in 2024
- By Type: In 2024, the Carbohydrases Segment is Expected to Dominate the Specialty Enzymes Market
- By Form: In 2024, the Liquid Segment is Expected to Account for a Larger Share of the Specialty Enzymes Market
- By Application: In 2024, the Pharmaceuticals Segment is Expected to Account for the Largest Share of the Specialty Enzymes Market
- By Geography: North America Dominates the Specialty Enzymes Market in 2024
Specialty Enzymes Market Growth Drivers
Growing Prevalence of Chronic Disorders
There is a rising prevalence of chronic disorders such as diabetes, cardiovascular conditions, and cancer, and it has become more common worldwide. The increasing prevalence of chronic disorders drives the demand for specialty enzymes, particularly in the healthcare and diagnostics sectors. According to the World Health Organization, chronic diseases make up 73% of all global deaths and an additional 60% of the global burden of disease. The rising prevalence of chronic diseases globally has increased the need for effective diagnostic tools that can facilitate early detection and personalized treatment plans.
Specialty enzymes act as vital biocatalysts in various diagnostic applications, including clinical chemistry, immunoassays, and molecular diagnostics, enabling rapid and accurate identification of disease biomarkers in biological samples. Furthermore, the COVID-19 pandemic highlighted the importance of rapid diagnostic capabilities, leading to heightened demand for specialty enzymes used in tests such as PCR assays. This trend is expected to continue as healthcare systems worldwide prioritize improved diagnostic technologies to manage both chronic and infectious diseases more effectively.
With a growing aging population and rising healthcare expenditures, the demand for innovative enzyme-based solutions is increasing. These factors are anticipated to drive the demand for specialty enzymes.
Increasing Demand from Pharmaceuticals and Biotechnology
Specialty enzymes play a crucial role in various stages of biopharmaceutical manufacturing, including protein expression, purification, and modification. They are essential for developing biologics, such as monoclonal antibodies and vaccines, which are increasingly important in treating chronic diseases like cancer and diabetes. The aging population and the rising incidence of these diseases further amplify the demand for innovative therapies, thus driving the need for specialty enzymes in drug formulation.
Furthermore, advancements in biotechnology and genetic engineering have led to the creation of more efficient enzymes tailored for specific applications. For instance, proteases are utilized in insulin production to enhance yield and efficiency, demonstrating their importance in meeting global healthcare demands. Additionally, the growing focus on regenerative medicine and cell-based therapies is propelling investments in specialty enzymes that can facilitate these advanced treatments.
Moreover, the pharmaceutical industry is increasingly adopting sustainable practices, with microbial enzymes gaining popularity due to their eco-friendly nature and efficiency. This shift aligns with global sustainability goals while also addressing the need for non-toxic biological catalysts. These factors are expected to drive the demand for specialty enzymes.
Specialty Enzymes Market Opportunity
Increasing Focus on Sustainable and Eco-friendly Processes
Enzymes play a vital role in eco-friendly manufacturing practices. As effective biocatalysts, they can replace harmful synthetic chemicals, thereby reducing environmental impact. Furthermore, industries such as pharmaceuticals and biotechnology are increasingly adopting enzyme-based processes to enhance efficiency and reduce pollution. For instance, enzymes used in drug production have shown significant reductions in both waste and energy use. Additionally, the trend toward green chemistry is encouraging manufacturers to invest in enzyme technologies that provide safer and more sustainable manufacturing solutions.
Furthermore, governments are implementing stricter environmental regulations, which further drives the adoption of eco-friendly practices. Thus, the growing emphasis on sustainable and eco-friendly processes is expected to support the growth of the specialty enzymes market.
Specialty Enzymes Market Analysis: Top Market Opportunity:
By Type: The Carbohydrases Segment to Dominate the Specialty Enzymes Market in 2024
Based on type, the specialty enzymes market is segmented into carbohydrases, protease, lipase, polymerases & nucleases, and other enzymes. In 2024, the carbohydrases segment is expected to account for the largest share of the specialty enzymes market. This segment’s large market share is primarily due to their wide range of applications across various industries, advancements in microbial production methods, and a growing focus on biopharmaceuticals and regenerative medicine.
Carbohydrases are a group of enzymes that catalyze the hydrolysis of carbohydrates, breaking them down into simpler sugars. These enzymes are primarily sourced from microbial organisms such as bacteria, yeasts, and fungi. Carbohydrases have diverse applications in industries, including pharmaceuticals, biotechnology, and diagnostics, where they serve as biocatalysts. They play a crucial role in the production of active pharmaceutical ingredients (APIs) by facilitating the breakdown of complex carbohydrates into simpler forms that can be utilized in drug formulation.
However, the polymerases & nucleases segment is projected to register the highest CAGR during the forecast period of 2024–2031. The growth of this segment is primarily driven by the increasing development of RNA-based therapeutics, rising demand for diagnostic assays, and a growing emphasis on biotechnological research. These enzymes are essential for synthesizing therapeutic RNA molecules, which play a critical role in modern medicine and vaccine development.
Geographical Analysis
North America Dominates the Specialty Enzymes Market
Based on geography, the specialty enzymes market is majorly segmented into five regions: North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. In 2024, North America is expected to account for the largest share of the specialty enzymes market, followed by Europe and Asia-Pacific. North America’s significant market share can be attributed to several key factors, including the increasing use of specialty enzymes in pharmaceuticals for drug manufacturing, diagnostics, and therapeutic applications to treat chronic diseases such as cancer and cardiovascular disorders.
Additionally, the rise in regenerative medicine applications and ongoing innovation in enzyme technology are anticipated to further boost the demand for specialty enzymes. In North America, the U.S. is expected to account for the larger share of the specialty enzymes market in 2024, driven by its robust pharmaceutical sector and increasing investments in biotechnology innovations.
However, the market in Asia-Pacific is expected to record the highest CAGR during the forecast period. The growth of this regional market is driven by technological advancements in the pharmaceuticals and biotechnology sectors, as well as increased R&D activities in the enzyme industry. Additionally, rising healthcare expenditures and a growing emphasis on pharmaceutical development in countries like India, Japan, and South Korea are anticipated to support the growth of the specialty enzymes market. Furthermore, China and India are projected to be the fastest-growing countries for the specialty enzymes market in this region during the forecast period.
Key Companies
The report offers a competitive analysis based on an extensive assessment of the leading players’ product portfolios and geographic presence and the key growth strategies adopted by them over the past three to four years. Some of the key players operating in the specialty enzymes market are Biocatalysts Ltd. (U.K.), Codexis, Inc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Amano Enzyme Inc. (Japan), Baduhenna Topco Limited (U.K.), Promega Corporation (U.S.), Advanced Enzyme Technologies Limited (India), Specialty Enzymes & Probiotics (U.S.), Merck KGaA (Germany), Aumgene Biosciences Pvt. Ltd. (India), Antozyme Biotech Pvt Ltd (India), Enzyme Development Corporation (U.S.), and Amicogen, Inc. (South Korea).
Specialty Enzymes Industry Overview: Latest Developments from Key Industry Players
- In May 2024, Biocatalysts Ltd (U.K.) completed the large-scale manufacture of a specialty ligase for a major pharmaceutical company. Large-scale chromatography enables the production of high-purity specialty enzymes in the pharmaceutical and life sciences industries.
- In May 2023, Codexis, Inc. (U.S.) launched enzyme-catalyzed oligonucleotide (ECO) synthesis technology, a proprietary new synthesis platform developed for manufacturing RNA oligonucleotide therapeutics at scale. This technology helps traditional method challenges and enables scalable and sustainable manufacturing.
- In January 2022, Merck KGaA (Germany) collaborated with Absci Corp. (U.S.) to develop new enzymes for the biopharmaceutical industry.
Specialty Enzymes Market Research Summary
|
Particulars |
Details |
|
Number of Pages |
170 |
|
Format |
|
|
Forecast Period |
2024–2031 |
|
Base Year |
2023 |
|
CAGR (Value) |
7.7% |
|
Market Size (Value) |
USD 6.47 Billion by 2031 |
|
Segments Covered |
By Source
By Type
By Form
By Application
|
|
Countries Covered |
North America (U.S., Canada), Europe (Germany, France, U.K., Italy, Spain, Rest of Europe), Asia-Pacific (China, India, Japan, Australia, South Korea, Rest of Asia-Pacific), Latin America (Brazil, Mexico, Argentina, Rest of Latin America), and the Middle East & Africa (South Africa, Saudi Arabia, UAE, the Rest of Middle East & Africa). |
|
Key Companies |
Biocatalysts Ltd. (U.K.), Codexis, Inc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Amano Enzyme Inc. (Japan), Baduhenna Topco Limited (U.K.), Promega Corporation (U.S.), Advanced Enzyme Technologies Limited (India), Specialty Enzymes & Probiotics (U.S.), Merck KGaA (Germany), Aumgene Biosciences Pvt. Ltd. (India), Antozyme Biotech Pvt Ltd (India), Enzyme Development Corporation (U.S.), and Amicogen, Inc. (South Korea). |
Key questions answered in the specialty enzymes market report:
The global specialty enzymes market size was valued at $3.58 billion in 2023.
The market is projected to grow from $3.84 billion in 2024 to $6.47 billion by 2031.
The specialty enzymes market analysis indicates substantial growth, with projections indicating that the market will reach $6.47 billion by 2031 at a compound annual growth rate (CAGR) of 7.7% from 2024 to 2031.
The key companies operating in this market include Biocatalysts Ltd. (U.K.), Codexis, Inc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Amano Enzyme Inc. (Japan), Baduhenna Topco Limited (U.K.), Promega Corporation (U.S.), Advanced Enzyme Technologies Limited (India), Specialty Enzymes & Probiotics (U.S.), Merck KGaA (Germany), Aumgene Biosciences Pvt. Ltd. (India), Antozyme Biotech Pvt Ltd (India), Enzyme Development Corporation (U.S.), and Amicogen, Inc. (South Korea).
The increasing focus on sustainable and eco-friendly processes and the expanding applications of biocatalysts are expected to create market growth opportunities for the stakeholders in this market.
By source, the microorganisms segment is forecasted to hold the largest market share during 2024-2031.
By type: the carbohydrases segment is expected to dominate the market during 2024-2031.
By form, the liquid segment is expected to hold the major share of the market during 2024-2031.
By application: the pharmaceuticals segment is expected to dominate the market during 2024-2031.
By geography, North America is anticipated to hold the major market share during 2024-2031.
By region, North America holds the largest specialty enzymes market share in 2024. However, the market in Asia-Pacific is expected to witness the fastest growth rate, driven by technological advancements in the pharmaceuticals and biotechnology sectors and the increase in R&D activities in the enzyme industry.
Key factors driving the growth of this market include the growing prevalence of chronic disorders, increasing demand from pharmaceuticals and biotechnology, and advancements in production technologies.
1. Introduction
1.1. Market Definition & Scope
1.2. Market Ecosystem
1.3. Currency
1.4. Key Stakeholders
2. Research Methodology
2.1. Research Approach
2.2. Data Collection and Validation Process
2.2.1. Secondary Research
2.2.2. Primary Research/Interviews with Key Opinion Leaders from the Industry
2.3. Market Sizing and Forecast
2.3.1. Market Size Estimation Approach
2.3.2. Growth Forecast Approach
2.4. Assumptions for the Study
3. Executive Summary
3.1. Overview
3.2. Segmental Analysis
3.2.1. Specialty Enzymes Market Analysis: by Source
3.2.2. Specialty Enzymes Market Analysis: by Type
3.2.3. Specialty Enzymes Market Analysis: by Form
3.2.4. Specialty Enzymes Market Analysis: by Application
3.3. Regional Analysis
3.4. Market Competitors & Competitive Landscape
4. Market Insights
4.1. Overview
4.2. Drivers
4.2.1. Increasing Prevalence of Chronic Diseases
4.2.2. Rising Demand from the Pharmaceuticals and Biotechnology Sectors
4.2.3. Advancements in Production Technologies
4.3. Restraints
4.3.1. Stringent Regulations
4.3.2. High Cost of Raw Material Prices
4.4. Opportunities
4.4.1. Increasing Focus on Sustainable and Eco-friendly Processes
4.4.2. Expansion of Biocatalyst Applications
4.5. Challenges
4.5.1. Growing Concerns Regarding Contamination
4.6. Porter’s Five Forces Analysis
4.6.1. Bargaining Power of Suppliers
4.6.2. Bargaining Power of Buyers
4.6.3. Threat of Substitutes
4.6.4. Threat of New Entrants
4.6.5. Degree of Competition
5. Specialty Enzymes Market Assessment—by Source
5.1. Overview
5.2. Microorganisms
5.3. Animal
5.4. Plant
6. Specialty Enzymes Market Assessment—by Type
6.1. Overview
6.2. Carbohydrases
6.3. Protease
6.4. Lipase
6.5. Polymerases & Nucleases
6.6. Other Enzymes
7. Specialty Enzymes Market Assessment—by Form
7.1. Overview
7.2. Liquid
7.3. Dry
8. Specialty Enzymes Market Assessment—by Application
8.1. Overview
8.2. Pharmaceuticals
8.3. Research & Biotechnology
8.4. Diagnostics
8.5. Biocatalysts
9. Specialty Enzymes Market Assessment—by Geography
9.1. Overview
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.3. Europe
9.3.1. Germany
9.3.2. France
9.3.3. U.K.
9.3.4. Spain
9.3.5. Italy
9.3.6. Russia
9.3.7. Rest of Europe
9.4. Asia-Pacific
9.4.1. China
9.4.2. India
9.4.3. Japan
9.4.4. Australia
9.4.5. South Korea
9.4.6. Rest of Asia-Pacific
9.5. Latin America
9.5.1. Brazil
9.5.2. Mexico
9.5.3. Argentina
9.5.4. Rest of Latin America
9.6. Middle East & Africa
9.6.1. Saudi Arabia
9.6.2. South Africa
9.6.3. UAE
9.6.4. Rest of Middle East & Africa
10. Competition Analysis
10.1. Overview
10.2. Key Growth Strategies
10.3. Competitive Benchmarking
10.4. Competitive Dashboard
10.4.1. Industry Leaders
10.4.2. Market Differentiators
10.4.3. Vanguards
10.4.4. Emerging Companies
10.5. Market Share/Ranking Analysis, by the Key Players, 2023
11. Company Profiles (Business Overview, Financial Overview, Product Portfolio, Strategic Developments)
11.1. Biocatalysts Ltd.
11.2. Codexis, Inc.
11.3. F. Hoffmann-La Roche Ltd
11.4. Amano Enzyme Inc.
11.5. Baduhenna Topco Limited
11.6. Promega Corporation
11.7. Advanced Enzyme Technologies Limited
11.8. Specialty Enzymes & Probiotics
11.9. Merck KGaA
11.10. Aumgene Biosciences Pvt. Ltd.
11.11. Antozyme Biotech Pvt Ltd
11.12. Enzyme Development Corporation
11.13. Amicogen, Inc.
11.14. Other Companies
(Note: SWOT Analyses of the Top 5 Companies Will be Provided)
12. Appendix
12.1. Available Customization
12.2. Related Reports
List of Tables
Table 1 Global Specialty Enzymes Market, by Source, 2022–2031 (USD Million)
Table 2 Global Microorganism-sourced Specialty Enzymes Market, by Country, 2022–2031 (USD Million)
Table 3 Global Animal-sourced Specialty Enzymes Market, by Country, 2022–2031 (USD Million)
Table 4 Global Plant-sourced Specialty Enzymes Market, by Country, 2022–2031 (USD Million)
Table 5 Global Specialty Enzymes Market, by Type, 2022–2031 (USD Million)
Table 6 Global Specialty Enzymes Market, by Type, 2022–2031 (MT)
Table 7 Global Carbohydrases Market, by Country, 2022–2031 (USD Million)
Table 8 Global Carbohydrases Market, by Country, 2022–2031 (MT)
Table 9 Global Protease Market, by Country, 2022–2031 (USD Million)
Table 10 Global Protease Market, by Country, 2022–2031 (MT)
Table 11 Global Lipase Market, by Country, 2022–2031 (USD Million)
Table 12 Global Lipase Market, by Country, 2022–2031 (MT)
Table 13 Global Polymerases & Nucleases Market, by Country, 2022–2031 (USD Million)
Table 14 Global Polymerases & Nucleases Market, by Country, 2022–2031 (MT)
Table 15 Global Other Enzymes Market, by Country, 2022–2031 (USD Million)
Table 16 Global Other Enzymes Market, by Country, 2022–2031 (MT)
Table 17 Global Specialty Enzymes Market, by Form, 2022–2031 (USD Million)
Table 18 Global Liquid Form Specialty Enzymes Market, by Country, 2022–2031 (USD Million)
Table 19 Global Dry Form Specialty Enzymes Market, by Country, 2022–2031 (USD Million)
Table 20 Global Specialty Enzymes Market, by Application, 2022–2031 (USD Million)
Table 21 Global Specialty Enzymes Market for Pharmaceuticals, by Country, 2022–2031 (USD Million)
Table 22 Global Specialty Enzymes Market for Research & Biotechnology, by Country, 2022–2031 (USD Million)
Table 23 Global Specialty Enzymes Market for Diagnostics, by Country, 2022–2031 (USD Million)
Table 24 Global Specialty Enzymes Market for Biocatalysts, by Country, 2022–2031 (USD Million)
Table 25 North America: Specialty Enzymes Market, by Country, 2022–2031 (USD Million)
Table 26 North America: Specialty Enzymes Market, by Country, 2022–2031 (MT)
Table 27 North America: Specialty Enzymes Market, by Source, 2022–2031 (USD Million)
Table 28 North America: Specialty Enzymes Market, by Type, 2022–2031 (USD Million)
Table 29 North America: Specialty Enzymes Market, by Type, 2022–2031 (MT)
Table 30 North America: Specialty Enzymes Market, by Form, 2022–2031 (USD Million)
Table 31 North America: Specialty Enzymes Market, by Application, 2022–2031 (USD Million)
Table 32 U.S.: Specialty Enzymes Market, by Source, 2022–2031 (USD Million)
Table 33 U.S.: Specialty Enzymes Market, by Type, 2022–2031 (USD Million)
Table 34 U.S.: Specialty Enzymes Market, by Type, 2022–2031 (MT)
Table 35 U.S.: Specialty Enzymes Market, by Form, 2022–2031 (USD Million)
Table 36 U.S.: Specialty Enzymes Market, by Application, 2022–2031 (USD Million)
Table 37 Canada: Specialty Enzymes Market, by Source, 2022–2031 (USD Million)
Table 38 Canada: Specialty Enzymes Market, by Type, 2022–2031 (USD Million)
Table 39 Canada: Specialty Enzymes Market, by Type, 2022–2031 (MT)
Table 40 Canada: Specialty Enzymes Market, by Form, 2022–2031 (USD Million)
Table 41 Canada: Specialty Enzymes Market, by Application, 2022–2031 (USD Million)
Table 42 Europe: Specialty Enzymes Market, by Country/Region, 2022–2031 (USD Million)
Table 43 Europe: Specialty Enzymes Market, by Country/Region, 2022–2031 (MT)
Table 44 Europe: Specialty Enzymes Market, by Source, 2022–2031 (USD Million)
Table 45 Europe: Specialty Enzymes Market, by Type, 2022–2031 (USD Million)
Table 46 Europe: Specialty Enzymes Market, by Type, 2022–2031 (MT)
Table 47 Europe: Specialty Enzymes Market, by Form, 2022–2031 (USD Million)
Table 48 Europe: Specialty Enzymes Market, by Application, 2022–2031 (USD Million)
Table 49 Germany: Specialty Enzymes Market, by Source, 2022–2031 (USD Million)
Table 50 Germany: Specialty Enzymes Market, by Type, 2022–2031 (USD Million)
Table 51 Germany: Specialty Enzymes Market, by Type, 2022–2031 (MT)
Table 52 Germany: Specialty Enzymes Market, by Form, 2022–2031 (USD Million)
Table 53 Germany: Specialty Enzymes Market, by Application, 2022–2031 (USD Million)
Table 54 France: Specialty Enzymes Market, by Source, 2022–2031 (USD Million)
Table 55 France: Specialty Enzymes Market, by Type, 2022–2031 (USD Million)
Table 56 France: Specialty Enzymes Market, by Type, 2022–2031 (MT)
Table 57 France: Specialty Enzymes Market, by Form, 2022–2031 (USD Million)
Table 58 France: Specialty Enzymes Market, by Application, 2022–2031 (USD Million)
Table 59 U.K.: Specialty Enzymes Market, by Source, 2022–2031 (USD Million)
Table 60 U.K.: Specialty Enzymes Market, by Type, 2022–2031 (USD Million)
Table 61 U.K.: Specialty Enzymes Market, by Type, 2022–2031 (MT)
Table 62 U.K.: Specialty Enzymes Market, by Form, 2022–2031 (USD Million)
Table 63 U.K.: Specialty Enzymes Market, by Application, 2022–2031 (USD Million)
Table 64 Italy: Specialty Enzymes Market, by Source, 2022–2031 (USD Million)
Table 65 Italy: Specialty Enzymes Market, by Type, 2022–2031 (USD Million)
Table 66 Italy: Specialty Enzymes Market, by Type, 2022–2031 (MT)
Table 67 Italy: Specialty Enzymes Market, by Form, 2022–2031 (USD Million)
Table 68 Italy: Specialty Enzymes Market, by Application, 2022–2031 (USD Million)
Table 69 Spain: Specialty Enzymes Market, by Source, 2022–2031 (USD Million)
Table 70 Spain: Specialty Enzymes Market, by Type, 2022–2031 (USD Million)
Table 71 Spain: Specialty Enzymes Market, by Type, 2022–2031 (MT)
Table 72 Spain: Specialty Enzymes Market, by Form, 2022–2031 (USD Million)
Table 73 Spain: Specialty Enzymes Market, by Application, 2022–2031 (USD Million)
Table 74 Rest of Europe: Specialty Enzymes Market, by Source, 2022–2031 (USD Million)
Table 75 Rest of Europe: Specialty Enzymes Market, by Type, 2022–2031 (USD Million)
Table 76 Rest of Europe: Specialty Enzymes Market, by Type, 2022–2031 (MT)
Table 77 Rest of Europe: Specialty Enzymes Market, by Form, 2022–2031 (USD Million)
Table 78 Rest of Europe: Specialty Enzymes Market, by Application, 2022–2031 (USD Million)
Table 79 Asia-Pacific: Specialty Enzymes Market, by Country/Region, 2022–2031 (USD Million)
Table 80 Asia-Pacific: Specialty Enzymes Market, by Country/Region, 2022–2031 (MT)
Table 81 Asia-Pacific: Specialty Enzymes Market, by Source, 2022–2031 (USD Million)
Table 82 Asia-Pacific: Specialty Enzymes Market, by Type, 2022–2031 (USD Million)
Table 83 Asia-Pacific: Specialty Enzymes Market, by Type, 2022–2031 (MT)
Table 84 Asia-Pacific: Specialty Enzymes Market, by Form, 2022–2031 (USD Million)
Table 85 Asia-Pacific: Specialty Enzymes Market, by Application, 2022–2031 (USD Million)
Table 86 China: Specialty Enzymes Market, by Source, 2022–2031 (USD Million)
Table 87 China: Specialty Enzymes Market, by Type, 2022–2031 (USD Million)
Table 88 China: Specialty Enzymes Market, by Type, 2022–2031 (MT)
Table 89 China: Specialty Enzymes Market, by Form, 2022–2031 (USD Million)
Table 90 China: Specialty Enzymes Market, by Application, 2022–2031 (USD Million)
Table 91 India: Specialty Enzymes Market, by Source, 2022–2031 (USD Million)
Table 92 India: Specialty Enzymes Market, by Type, 2022–2031 (USD Million)
Table 93 India: Specialty Enzymes Market, by Type, 2022–2031 (MT)
Table 94 India: Specialty Enzymes Market, by Form, 2022–2031 (USD Million)
Table 95 India: Specialty Enzymes Market, by Application, 2022–2031 (USD Million)
Table 96 Japan: Specialty Enzymes Market, by Source, 2022–2031 (USD Million)
Table 97 Japan: Specialty Enzymes Market, by Type, 2022–2031 (USD Million)
Table 98 Japan: Specialty Enzymes Market, by Type, 2022–2031 (MT)
Table 99 Japan: Specialty Enzymes Market, by Form, 2022–2031 (USD Million)
Table 100 Japan: Specialty Enzymes Market, by Application, 2022–2031 (USD Million)
Table 101 Australia: Specialty Enzymes Market, by Source, 2022–2031 (USD Million)
Table 102 Australia: Specialty Enzymes Market, by Type, 2022–2031 (USD Million)
Table 103 Australia: Specialty Enzymes Market, by Type, 2022–2031 (MT)
Table 104 Australia: Specialty Enzymes Market, by Form, 2022–2031 (USD Million)
Table 105 Australia: Specialty Enzymes Market, by Application, 2022–2031 (USD Million)
Table 106 South Korea: Specialty Enzymes Market, by Source, 2022–2031 (USD Million)
Table 107 South Korea: Specialty Enzymes Market, by Type, 2022–2031 (USD Million)
Table 108 South Korea: Specialty Enzymes Market, by Type, 2022–2031 (MT)
Table 109 South Korea: Specialty Enzymes Market, by Form, 2022–2031 (USD Million)
Table 110 South Korea: Specialty Enzymes Market, by Application, 2022–2031 (USD Million)
Table 111 Rest of Asia-Pacific: Specialty Enzymes Market, by Source, 2022–2031 (USD Million)
Table 112 Rest of Asia-Pacific: Specialty Enzymes Market, by Type, 2022–2031 (USD Million)
Table 113 Rest of Asia-Pacific: Specialty Enzymes Market, by Type, 2022–2031 (MT)
Table 114 Rest of Asia-Pacific: Specialty Enzymes Market, by Form, 2022–2031 (USD Million)
Table 115 Rest of Asia-Pacific: Specialty Enzymes Market, by Application, 2022–2031 (USD Million)
Table 116 Latin America: Specialty Enzymes Market, by Country/Region, 2022–2031 (USD Million)
Table 117 Latin America: Specialty Enzymes Market, by Country/Region, 2022–2031 (MT)
Table 118 Latin America: Specialty Enzymes Market, by Source, 2022–2031 (USD Million)
Table 119 Latin America: Specialty Enzymes Market, by Type, 2022–2031 (USD Million)
Table 120 Latin America: Specialty Enzymes Market, by Type, 2022–2031 (MT)
Table 121 Latin America: Specialty Enzymes Market, by Form, 2022–2031 (USD Million)
Table 122 Latin America: Specialty Enzymes Market, by Application, 2022–2031 (USD Million)
Table 123 Brazil: Specialty Enzymes Market, by Source, 2022–2031 (USD Million)
Table 124 Brazil: Specialty Enzymes Market, by Type, 2022–2031 (USD Million)
Table 125 Brazil: Specialty Enzymes Market, by Type, 2022–2031 (MT)
Table 126 Brazil: Specialty Enzymes Market, by Form, 2022–2031 (USD Million)
Table 127 Brazil: Specialty Enzymes Market, by Application, 2022–2031 (USD Million)
Table 128 Mexico: Specialty Enzymes Market, by Source, 2022–2031 (USD Million)
Table 129 Mexico: Specialty Enzymes Market, by Type, 2022–2031 (USD Million)
Table 130 Mexico: Specialty Enzymes Market, by Type, 2022–2031 (MT)
Table 131 Mexico: Specialty Enzymes Market, by Form, 2022–2031 (USD Million)
Table 132 Mexico: Specialty Enzymes Market, by Application, 2022–2031 (USD Million)
Table 133 Argentina: Specialty Enzymes Market, by Source, 2022–2031 (USD Million)
Table 134 Argentina: Specialty Enzymes Market, by Type, 2022–2031 (USD Million)
Table 135 Argentina: Specialty Enzymes Market, by Type, 2022–2031 (MT)
Table 136 Argentina: Specialty Enzymes Market, by Form, 2022–2031 (USD Million)
Table 137 Argentina: Specialty Enzymes Market, by Application, 2022–2031 (USD Million)
Table 138 Rest of Latin America: Specialty Enzymes Market, by Source, 2022–2031 (USD Million)
Table 139 Rest of Latin America: Specialty Enzymes Market, by Type, 2022–2031 (USD Million)
Table 140 Rest of Latin America: Specialty Enzymes Market, by Type, 2022–2031 (MT)
Table 141 Rest of Latin America: Specialty Enzymes Market, by Form, 2022–2031 (USD Million)
Table 142 Rest of Latin America: Specialty Enzymes Market, by Application, 2022–2031 (USD Million)
Table 143 Middle East & Africa: Specialty Enzymes Market, by Country/Region, 2022–2031 (USD Million)
Table 144 Middle East & Africa: Specialty Enzymes Market, by Country/Region, 2022–2031 (MT)
Table 145 Middle East & Africa: Specialty Enzymes Market, by Source, 2022–2031 (USD Million)
Table 146 Middle East & Africa: Specialty Enzymes Market, by Type, 2022–2031 (USD Million)
Table 147 Middle East & Africa: Specialty Enzymes Market, by Type, 2022–2031 (MT)
Table 148 Middle East & Africa: Specialty Enzymes Market, by Form, 2022–2031 (USD Million)
Table 149 Middle East & Africa: Specialty Enzymes Market, by Application, 2022–2031 (USD Million)
Table 150 South Africa: Specialty Enzymes Market, by Source, 2022–2031 (USD Million)
Table 151 South Africa: Specialty Enzymes Market, by Type, 2022–2031 (USD Million)
Table 152 South Africa: Specialty Enzymes Market, by Type, 2022–2031 (MT)
Table 153 South Africa: Specialty Enzymes Market, by Form, 2022–2031 (USD Million)
Table 154 South Africa: Specialty Enzymes Market, by Application, 2022–2031 (USD Million)
Table 155 Saudi Arabia: Specialty Enzymes Market, by Source, 2022–2031 (USD Million)
Table 156 Saudi Arabia: Specialty Enzymes Market, by Type, 2022–2031 (USD Million)
Table 157 Saudi Arabia: Specialty Enzymes Market, by Type, 2022–2031 (MT)
Table 158 Saudi Arabia: Specialty Enzymes Market, by Form, 2022–2031 (USD Million)
Table 159 Saudi Arabia: Specialty Enzymes Market, by Application, 2022–2031 (USD Million)
Table 160 UAE: Specialty Enzymes Market, by Source, 2022–2031 (USD Million)
Table 161 UAE: Specialty Enzymes Market, by Type, 2022–2031 (USD Million)
Table 162 UAE: Specialty Enzymes Market, by Type, 2022–2031 (MT)
Table 163 UAE: Specialty Enzymes Market, by Form, 2022–2031 (USD Million)
Table 164 UAE: Specialty Enzymes Market, by Application, 2022–2031 (USD Million)
Table 165 Rest of Middle East & Africa: Specialty Enzymes Market, by Source, 2022–2031 (USD Million)
Table 166 Rest of Middle East & Africa: Specialty Enzymes Market, by Type, 2022–2031 (USD Million)
Table 167 Rest of Middle East & Africa: Specialty Enzymes Market, by Type, 2022–2031 (MT)
Table 168 Rest of Middle East & Africa: Specialty Enzymes Market, by Form, 2022–2031 (USD Million)
Table 169 Rest of Middle East & Africa: Specialty Enzymes Market, by Application, 2022–2031 (USD Million)
Table 170 Recent Developments, by Company (2021–2024)
List of Figures
Figure 1 Research Process
Figure 2 Secondary Sources Referenced for This Study
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply-side & Demand-side)
Figure 6 Market Sizing and Growth Forecast Approach
Figure 7 The Microorganisms Segment is Expected to Dominate the Global Specialty Enzymes Market in 2024
Figure 8 The Carbohydrases Segment is Expected to Dominate the Global Specialty Enzymes Market in 2024
Figure 9 The Liquid Segment is Expected to Dominate the Global Specialty Enzymes Market in 2024
Figure 10 The Pharmaceuticals Segment is Expected to Dominate the Global Specialty Enzymes Market in 2024
Figure 11 North America is Expected to Dominate the Specialty Enzymes Market in 2024
Figure 12 Impact Analysis of Market Dynamics
Figure 13 Specialty Enzymes Market: Porter’s Five Forces Analysis
Figure 14 Global Specialty Enzymes Market, by Source, 2024 Vs. 2031 (USD Million)
Figure 15 Global Specialty Enzymes Market, by Type, 2024 Vs. 2031 (USD Million)
Figure 16 Global Specialty Enzymes Market, by Form, 2024 Vs. 2031 (USD Million)
Figure 17 Global Specialty Enzymes Market, by Application, 2024 Vs. 2031 (USD Million)
Figure 18 Global Specialty Enzymes Market, by Region, 2024 Vs. 2031 (USD Million)
Figure 19 North America: Specialty Enzymes Market Snapshot (2024)
Figure 20 Europe: Specialty Enzymes Market Snapshot (2024)
Figure 21 Asia-Pacific: Specialty Enzymes Market Snapshot (2024)
Figure 22 Latin America: Specialty Enzymes Market Snapshot (2024)
Figure 23 Middle East & Africa: Specialty Enzymes Market Snapshot (2024)
Figure 24 Key Growth Strategies Adopted by Leading Players (2021–2024)
Figure 25 Global Specialty Enzymes Market Competitive Benchmarking
Figure 26 Competitive Dashboard: Specialty Enzymes Market
Figure 27 Codexis, Inc.: Financial Overview (2023)
Figure 28 F. Hoffmann-La Roche Ltd.: Financial Overview (2023)
Figure 29 Merck KGaA: Financial Overview (2023)
Figure 30 Amicogen, Inc.: Financial Overview (2024)
Proudly Partnering With Enterprises Around the Globe
Quick Contact
Related Reports
Enzymes Market - Global Opportunity Analysis and Industry Forecast (2022-2029)
Published Date: Oct-2024
Specialty Food Ingredients Market - Global Opportunity Analysis And Industry Forecast (2024-2031)
Published Date: Jan-2024
Food Enzymes Market - Global Opportunity Analysis and Industry Forecast (2023-2030)
Published Date: Jun-2023
Specialty Yeast Market - Global Opportunity Analysis and Industry Forecast (2019-2025)
Published Date: Sep-2019
Baking Ingredients Market - Global Opportunity Analysis and Industry Forecast (2024-2030)
Published Date: Jun-2024
